Sevion Therapeutics COO Gregory Williams' 2018 pay jumps 147% to $6M

Sevion Therapeutics reports 2018 executive compensation

By ExecPay News

Published: April 5, 2019

Sevion Therapeutics reported fiscal year 2018 executive compensation information on April 5, 2019.
In 2018, four executives at Sevion Therapeutics received on average a compensation package of $2.9M, a 12% increase compared to previous year.
Average pay of disclosed executives at Sevion Therapeutics
Gregory Williams, Chief Operating Officer, received $6M in total. 94% of Williams' compensation, or $5.7M, was in option awards. Williams also received $50K in bonus, $78K in non-equity incentive plan, $245K in salary, as well as $10K in other compensation.
David P. Snow, Chief Business Officer, received a compensation package of $4.1M. 91% of the compensation package, or $3.8M, was in option awards.
Robert E. Ward, Chief Executive Officer, earned $904K in 2018, a 90% decrease compared to previous year.
Gregory Weaver, Chief Financial Officer, received $522K in 2018, which decreases by 67% compared to 2017.

Related executives

Robert Ward

Sevion Therapeutics

Chief Executive Officer

Gregory Weaver

Sevion Therapeutics

Chief Financial Officer

Gregory Williams

Sevion Therapeutics

Chief Operating Officer

David Snow

Sevion Therapeutics

Chief Business Officer

You may also like

Source: SEC filing on April 5, 2019.